HOME >> BIOLOGY >> NEWS
Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure

(Philadelphia, PA) The events that lead to cardiac hypertrophy, the enlargement of heart muscle cells, may be stopped by histone deacetylase (HDAC) inhibitors, a class of therapeutic agents currently under development as cancer drugs, according to researchers at the University of Pennsylvania School of Medicine. Cardiac hypertrophy is one of the leading causes of congestive heart failure, the most common diagnosis given for discharged hospital patients in the United States.

In the September issue of Journal of Clinical Investigation, the Penn researchers suggest novel genetic causes for and new therapeutic agents against cardiac hypertrophy and heart failure. Furthermore, the researchers demonstrate that anti-HDAC drugs can block the development of hypertrophy in animal models.

"In our studies, we determined that valproic acid, an HDAC inhibitor used to treat seizure disorders, is effective in preventing heart muscle cells from enlarging," said Jonathan A. Epstein, MD, Associate Professor in the division of Cardiovascular Medicine within Penn's Department of Medicine. "In recent years, drug companies have also begun developing more advanced HDAC inhibitors to treat cancer. These HDAC inhibitors may be among the first known medications to prevent cardiac hypertrophy."

Cardiac hypertrophy can be a healthy physiological response to events, such as aerobic exercise, where heart cells grow larger like any other well-conditioned muscle. Pathological hypertrophy, however, may result from genetic mutation or, most commonly, from the consequences of an unhealthy cardiovascular system.

"The exertion of pushing blood against high resistance in the setting of high blood pressure or overcompensation for heart muscle lost during a heart attack can cause heart muscle cells to enlarge," said Epstein. "While it might be helpful at first, hypertrophy can increase the stress placed on the heart and begin a downward spiral of events that ultimately leads
'"/>

Contact: Greg Lester
lesterg@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
15-Sep-2003


Page: 1 2

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental hantavirus vaccine elicits strong antibody response in primates
7. Experimental Biology 2003 meets in San Diego April 11-15
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental gene switch increases lifespan with no ill effects
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2018)... ... November 19, 2018 , ... ... research tools, drug development, agriculture, human clinical therapeutics, and animal and disease model), ... Technology (drug compound and target screening, and agriculture and industrial use), by Patent ...
(Date:11/20/2018)... ... November 20, 2018 , ... Like many large breed dogs, ... Before he was a year old, his mom, Rebecca, noticed he was slow to ... by her veterinarian and her suspicions were confirmed: Jack had bilateral hip dysplasia, a ...
(Date:11/15/2018)... ... November 15, 2018 , ... Superior Controls, Inc. , ... with 140 employees on both the east and west coasts, today announced the ... CSIA Certified control system integrators must pass an intensive audit every three years ...
Breaking Biology News(10 mins):
(Date:11/11/2018)... SAN DIEGO (PRWEB) , ... November 09, 2018 , ... ... named a CES® 2019 Innovation Awards Honoree for DFree ®, the ... and notifies you when it’s time to go to the bathroom. The announcement was ...
(Date:11/7/2018)... BOSTON (PRWEB) , ... November 07, 2018 , ... ... Asymmetrex has been leading a campaign to increase awareness of the adult tissue ... industry. During the month of November, the company is intensifying this effort with ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings Inc., the ... and several healthcare VC firms announces at Distributed Health 2018 conference November 5-6 ... purchasing tokens and obtaining its first radiology interpretations, one of the first known ...
(Date:11/3/2018)... ... November 01, 2018 , ... Triangle Insights Group, a premier life ... of the fastest-growing private companies in the United States, appearing on this year’s Inc. ... companies based on percentage revenue growth over the previous three years. , Separately, ...
Breaking Biology Technology:
Cached News: